Assessment of using fingerstick blood sample with i-STAT point-of-care device for cardiac troponin I assay

被引:15
作者
Loewenstein, Devin [1 ]
Stake, Christine [2 ]
Cichon, Mark [3 ]
机构
[1] Loyola Univ Chicago, Stritch Sch Med, Maywood, IL USA
[2] Loyola Univ, Med Ctr, Emergency Med Serv, Maywood, IL 60153 USA
[3] Loyola Univ, Med Ctr, Dept Emergency Med, Maywood, IL 60153 USA
关键词
ACUTE CORONARY SYNDROMES; EARLY-DIAGNOSIS; TRIAL;
D O I
10.1016/j.ajem.2013.04.031
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Purposes: The purpose of this study is to compare fingerstick point-of-care (POC) testing for cardiac troponin I to conventional venipuncture POC testing using the i-STAT device. Basic procedures: This study was conducted with institutional review board approval in the emergency department (ED) of a 535-bed suburban level I trauma center from June to August 2011. Fingerstick blood samples were collected from consenting patients for whom standard-of-care venipuncture POC troponin (POCT) testing had been ordered as part of their workup. Cardiac troponin I (cTnI) assays were performed using the i-STAT 1 device (Abbott Point of Care, Princeton, NJ). The data were subjected to categorical comparison, linear regression, and Bland-Altman agreement analysis using SAS 9.2 software (SAS, Cary, NC). Main findings: Eighty-nine cTnI levels were measured by both fingerstick and standard venipuncture ED POC testing. Four resulted in cartridge error; the remaining 85 were analyzed. Fingerstick testing, compared with standard ED POCT, has a positive predictive value of 1.00 (0.48, 1.00), negative predictive value of 0.96 (0.89, 0.99), sensitivity of 0.625 (0.24, 0.91), and specificity of 1.00 (0.95, 1.00). The relationship between methods appears linear, with linear regression equation ED POCT level = 0.0062 + 1.3752 * fingerstick level (P < 0.0001). Bland-Altman agreement analysis yielded a mean difference between fingerstick and ED POCT of -0.0095 with limits of agreement of -0.0625 to 0.0435. Principal conclusions: Fingerstick cTnI testing using the i-STAT device is not accurate enough to determine the exact troponin level without the application of a corrective term. Fingerstick testing is, however, accurate in qualifying troponin levels as negative, borderline, or positive and is, therefore, capable of providing clinical information that may guide diagnostic and therapeutic decision making. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1236 / 1239
页数:4
相关论文
共 7 条
  • [1] Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial
    Collinson, Paul
    Goodacre, Steve
    Gaze, David
    Gray, Alasdair
    Arrowsmith, Charlotte
    Barth, Julian
    Benger, Jonathan
    Bradburn, Mike
    Capwell, Simon
    Chater, Tim
    Coats, Tim
    Cooper, Cindy
    Cooper, Mandy
    Coyle, Judy
    Cross, Liz
    Dixon, Simon
    Fitzgerald, Patrick
    Gendall, Emma
    Goodwin, Emma
    Hall, Alistair
    Hall, Kevin
    Hassan, Taj
    Humphrey, Julian
    Julious, Steven
    Kendall, Jason
    Lawlor, Vanessa
    Mackness, Sue
    Meades, Yvonne
    Newby, David
    Newell, Dawn
    Quartey, Doris
    Robinson, Karen
    Sibbick, Glen
    Smith, Jason
    Squire, Roz
    [J]. HEART, 2012, 98 (04) : 312 - 318
  • [2] Sensitive Troponin I Assay in Early Diagnosis of Acute Myocardial Infarction.
    Keller, Till
    Zeller, Tanja
    Peetz, Dirk
    Tzikas, Stergios
    Roth, Alexander
    Czyz, Ewa
    Bickel, Christoph
    Baldus, Stephan
    Warnholtz, Ascan
    Froehlich, Meike
    Sinning, Christoph R.
    Eleftheriadis, Medea S.
    Wild, Philipp S.
    Schnabel, Renate B.
    Lubos, Edith
    Jachmann, Nicole
    Genth-Zotz, Sabine
    Post, Felix
    Nicaud, Viviane
    Tiret, Laurence
    Lackner, Karl J.
    Muenzel, Thomas
    Blankenberg, Stefan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (09) : 868 - 877
  • [3] Validation of a point of care troponin assay in real life emergency department conditions
    Loten, Conrad
    Attia, John
    Hullick, Carolyn
    Marley, John
    McElduff, Patrick
    [J]. EMERGENCY MEDICINE AUSTRALASIA, 2009, 21 (04) : 286 - 292
  • [4] Impact of point-of-care testing in the emergency department evaluation and treatment of patients with suspected acute coronary syndromes
    Renaud, Bertrand
    Maison, Patrick
    Ngako, Alfred
    Cunin, Patrick
    Santin, Aline
    Herve, Jerome
    Salloum, Mirna
    Calmettes, Marie-Jeanne
    Boraud, Cyril
    Lemiale, Virginie
    Grego, Jean Claude
    Debacker, Marie
    Hemery, Francois
    Roupie, Eric
    [J]. ACADEMIC EMERGENCY MEDICINE, 2008, 15 (03) : 216 - 224
  • [5] A Multicenter Randomized Controlled Trial Comparing Central Laboratory and Point-of-Care Cardiac Marker Testing Strategies: The Disposition Impacted by Serial Point of Care Markers in Acute Coronary Syndromes (DISPO-ACS) Trial
    Ryan, Richard J.
    Lindsell, Christopher J.
    Hollander, Judd E.
    O'Neil, Brian
    Jackson, Raymond
    Schreiber, Donald
    Christenson, Robert
    Gibler, W. Brian
    [J]. ANNALS OF EMERGENCY MEDICINE, 2009, 53 (03) : 321 - 328
  • [6] Early and late outcome prediction of death in the emergency room setting by point-of-care and laboratory assays of cardiac troponin I
    Venge, Per
    Ohberg, Claes
    Flodin, Mats
    Lindahl, Bertil
    [J]. AMERICAN HEART JOURNAL, 2010, 160 (05) : 835 - 841
  • [7] Venturini J, 2011, P AM AC EM MED ANN M